Earnings Per Share, Basic of Dianthus Therapeutics, Inc. /DE/ from 31 Dec 2020 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Dianthus Therapeutics, Inc. /DE/ quarterly and annual Earnings Per Share, Basic in USD/shares history and change rate from 31 Dec 2020 to 31 Dec 2025.
  • Dianthus Therapeutics, Inc. /DE/ Earnings Per Share, Basic for the quarter ending 31 Dec 2025 was -1.53, a 101% decline year-over-year.
  • Dianthus Therapeutics, Inc. /DE/ Earnings Per Share, Basic for the twelve months ending 31 Dec 2025 was -4.2, a 65% decline year-over-year.
  • Dianthus Therapeutics, Inc. /DE/ annual Earnings Per Share, Basic for 2025 was -4.2, a 65% decline from 2024.
  • Dianthus Therapeutics, Inc. /DE/ annual Earnings Per Share, Basic for 2024 was -2.55, a 70% increase from 2023.
  • Dianthus Therapeutics, Inc. /DE/ annual Earnings Per Share, Basic for 2023 was -8.45, a 74% increase from 2022.
Source SEC data
View on sec.gov
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)

Dianthus Therapeutics, Inc. /DE/ Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 -4.2 -1.53 -0.77 -101% 01 Oct 2025 31 Dec 2025 10-K 09 Mar 2026 2025 FY
Q3 2025 -3.43 -0.97 -0.23 -31% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 -3.2 -0.88 -0.37 -73% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 -2.83 -0.82 -0.28 -52% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 -2.55 -0.76 -16.92 -105% 01 Oct 2024 31 Dec 2024 10-K 09 Mar 2026 2025 FY
Q3 2024 14.37 -0.74 +3.04 +80% 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025 2025 Q3
Q2 2024 11.33 -0.51 +12.22 +96% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 -0.89 -0.54 +7.56 +93% 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025 2025 Q1
Q4 2023 -8.45 16.16 +39.15 01 Oct 2023 31 Dec 2023 10-K 11 Mar 2025 2024 FY
Q3 2023 -47.6 -3.78 +5.12 +58% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 -52.72 -12.73 -12.44 -4290% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 -40.28 -8.1 -7.71 -1977% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 -32.57 -22.99 -8.96 -64% 01 Oct 2022 31 Dec 2022 10-K 21 Mar 2024 2023 FY
Q3 2022 -23.61 -8.9 -8.6 -2867% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 -15.01 -0.29 +0.03 +9.4% 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023 2023 Q2
Q1 2022 -15.04 -0.39 -0.03 -8.3% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q4 2021 -15.01 -14.03 01 Oct 2021 31 Dec 2021 8-K 21 Dec 2023
Q3 2021 -0.3 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022 2022 Q3
Q2 2021 -0.32 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022 2022 Q2
Q1 2021 -0.36 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q1

Dianthus Therapeutics, Inc. /DE/ Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 -4.2 -1.65 -65% 01 Jan 2025 31 Dec 2025 10-K 09 Mar 2026 2025 FY
2024 -2.55 +5.9 +70% 01 Jan 2024 31 Dec 2024 10-K 09 Mar 2026 2025 FY
2023 -8.45 +24.12 +74% 01 Jan 2023 31 Dec 2023 10-K 11 Mar 2025 2024 FY
2022 -32.57 -17.56 -117% 01 Jan 2022 31 Dec 2022 10-K 21 Mar 2024 2023 FY
2021 -15.01 -13.3 -778% 01 Jan 2021 31 Dec 2021 8-K 21 Dec 2023
2020 -1.71 01 Jan 2020 31 Dec 2020 10-K 08 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.